Vaccines: from empirical development to rational design

Christine Rueckert1, Carlos A Guzmán

  • 1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Plos Pathogens
|November 13, 2012
PubMed

Insights

Rational vaccine design is crucial for combating infectious diseases and multi-drug-resistant strains. This review explores advancements in tailored antigens, adjuvants, and delivery systems for effective vaccine development.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Disease Research

Background:

  • Infectious diseases cause significant global mortality, often exacerbated by multi-drug-resistant strains.
  • Vaccination is a key prevention strategy, but pathogen immune escape hinders vaccine development.
  • Current vaccines are largely empirically designed, necessitating a shift towards rational approaches.

Purpose of the Study:

  • To highlight the necessity of rational vaccine design over empirical methods.
  • To review recent advancements in rationally designing vaccine components like antigens, adjuvants, and delivery systems.
  • To identify methodological gaps and knowledge deficits impeding rational vaccine development.

Main Methods:

  • Literature review of recent developments in vaccine design strategies.
  • Analysis of advancements in antigen tailoring, adjuvant selection, and delivery systems.
  • Discussion of existing challenges and future directions in rational vaccine development.

Main Results:

  • Significant progress has been made in developing specifically tailored antigens, adjuvants, and delivery systems.
  • Methodological gaps and knowledge limitations still pose challenges to fully realizing rational vaccine design.
  • Various strategies and technologies show promise for advancing vaccine development.

Conclusions:

  • Rational vaccine design is essential for overcoming challenges posed by infectious diseases and antimicrobial resistance.
  • Continued research into tailored components and delivery systems is needed to bridge current knowledge gaps.
  • Exploring diverse strategies and technologies will accelerate the development of more effective vaccines.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...